Form 4: Arteris VP Sells Shares After Option Exercise

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised options and subsequently sold 5,000 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), engaged in a pre-planned transaction on November 3, 2025.
• Alpern exercised options to acquire 5,000 shares of common stock at an exercise price of $0.56 per share.
• Immediately following the option exercise, Alpern sold 5,000 shares of common stock at a weighted average price of $13.162 per share.
• The sales occurred within a price range of $12.98 to $13.59.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on June 5, 2025.
• Following these transactions, Alpern beneficially owns 65,960 shares of common stock and 80,000 derivative securities (options).

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While it's an insider sale, it's pre-planned and represents a significant gain for the insider, which could be seen as a positive signal on the stock's performance since the options were granted. The remaining significant holding also indicates continued alignment.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned sales and reducing concerns about opportunistic insider trading.
• The sale price of $13.162 per share is significantly higher than the exercise price of $0.56, indicating a substantial gain for the insider.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.

Future Outlook

NA

Industry Context

This Form 4 filing reports a routine insider transaction for Arteris, Inc., a company likely involved in semiconductor IP or related technology, given its focus on design and licensing. Such transactions are common for executives managing their personal equity holdings, especially when options vest and are exercised. The use of a 10b5-1 plan is standard practice for insiders to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: Slight dilution from option exercise (if new shares issued, but often treasury shares are used) and a minor reduction in insider ownership. The pre-planned nature mitigates negative sentiment.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction where an executive exercised options and subsequently sold shares. The transaction was executed under a 10b5-1 plan, which suggests it was not based on new material non-public information. While an insider sale reduces direct ownership, the significant gain realized by the executive (selling at $13.162 after exercising at $0.56) indicates past stock appreciation. The remaining substantial holdings (65,960 shares and 80,000 options) suggest continued alignment with shareholder interests. Without additional company-specific news or broader market context, this filing alone does not warrant a change from a 'hold' position, as it's a standard personal financial management event for an executive.

Keywords

Arteris Inc., AIP, Insider Trading, Form 4, Stock Sale, Option Exercise, Paul L. Alpern, 10b5-1 Plan, Corporate Governance